Response to Preoperative Dexamethasone Predicts Postoperative Neurological Improvement of Focal Neurological Deficits in Patients With Brain Metastases
- 13 January 2023
- journal article
- research article
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 92 (6) , 1227-1233
Abstract
BACKGROUND: Steroids are used ubiquitously in the preoperative management of patients with brain tumor. The rate of improvement in focal deficits with steroids and the prognostic value of such a response are not known. OBJECTIVE: To determine the rate at which focal neurological deficits respond to preoperative corticosteroids in patients with brain metastases and whether such an improvement could predict long-term recovery of neurological function after surgery. METHODS: Patients with brain metastases and related deficits in language, visual field, or motor domains who received corticosteroids before surgery were identified. Characteristics between steroid responders and nonresponders were compared. RESULTS: Ninety six patients demonstrated a visual field (13 patients), language (19), or motor (64) deficit and received dexamethasone in the week before surgery (average cumulative dose 43 mg; average duration 2.7 days). 38.5% of patients' deficits improved with steroids before surgery, while 82.3% of patients improved by follow-up. Motor deficits were more likely to improve both preoperatively (P = .014) and postoperatively (P = .010). All 37 responders remained improved at follow-up whereas 42 of 59 (71%) of nonresponders ultimately improved (P < .001). All other clinical characteristics, including dose and duration, were similar between groups. CONCLUSION: A response to steroids before surgery is highly predictive of long-term improvement postoperatively in brain metastasis patients with focal neurological deficits. Lack of a response portends a somewhat less favorable prognosis. Duration and intensity of therapy do not seem to affect the likelihood of response.Keywords
This publication has 18 references indexed in Scilit:
- Steroid management in newly diagnosed glioblastomaJournal of Neuro-Oncology, 2013
- Perioperative Steroids for Peritumoral Intracranial EdemaJournal of Neurosurgical Anesthesiology, 2012
- Corticosteroids in brain cancer patients: benefits and pitfallsExpert Review of Clinical Pharmacology, 2011
- Palliative Care in Lung CancerChest, 2007
- EFNS Guidelines on diagnosis and treatment of brain metastases: report of an EFNS Task ForceEuropean Journal of Neurology, 2006
- Current Management of Brain Metastases, With a Focus on Systemic OptionsJournal of Clinical Oncology, 2005
- Effects of dexamethasone on peritumoural oedematous brain: a DT-MRI studyJournal of Neurology, Neurosurgery & Psychiatry, 2004
- Dose‐effect relationship of dexamethasone on Karnofsky performance in metastatic brain tumorsNeurology, 1994
- Resorption of peritumoural oedema in cerebral gliomas during dexamethasone treatment evaluated by NMR relaxation time imagingActa Neurochirurgica, 1993
- BRAIN WATER MEASURED BY MAGNETIC RESONANCE IMAGINGThe Lancet, 1987